Skip to content

Epidaurus · Treatment Guide · Therapeutic Interventions

Going abroad for —

Transplant Capabilities

Organ transplant availability, outcomes, and wait times for foreigners

The country comparison

Which countries are best for transplant capabilities

The destinations ranked high→low under this lens — each with the reasoning behind its score, the cited evidence one click down, and its full report. The verdict is free; the report is the depth.

19 / 19 Countries ranked

Researched and assessed by the Epidaurus editorial pipeline against our published scale. A country below the rule is not yet assessed enough — never ranked last.

  1. 1 South Korea KR 4.5/5 Good South Korea operates five JCI-accredited transplant centers with world-leading living donor expertise and outcomes (kidney 98.4%, liver 90.4%, heart 91.6% at 1-year survival—all exceeding Score 5 thresholds), comprehe... Full report
    The evidence behind this score 5 cited points
    • Five JCI-accredited transplant centers (Asan, Samsung, Severance, SNUH, Seoul St. Mary's) with mature international patient departments
    • Kidney survival 98.4% at 1 year; liver LDLT 90.4% at 3 years; heart 91.6% at 1 year—exceeding international benchmarks
    • Foreign patients statutorily restricted to living donor transplants; KONOS excludes them from deceased donor allocation
    • Kidney transplant costs USD 40,000–81,000; liver USD 150,000–250,000 (50-90% below US equivalents)
    • Asan Medical Center holds world record with 6,000 cumulative living donor liver transplants and pioneered ABO-incompatible transplantation at scale

    Read the full South Korea report →

  2. 2 India IN 4.5/5 Good India exceeds most Score 5 criteria for living-donor transplant tourism: 10+ major accredited centers (45+ JCI-accredited hospitals), 5 organ types, wait times of 6-8 weeks for kidney and 2-4 weeks for liver transplan... Full report
    The evidence behind this score 6 cited points
    • 10+ major transplant centers actively serving international patients with 5 organ types available (kidney, liver, heart, lung, pancreas), with 45+ JCI-accredited hospitals nationally
    • 1,851 organ transplants performed on foreign nationals in 2023 (far exceeding 200+ annual threshold), with 1,445 in Delhi-NCR region
    • Wait times of 6-8 weeks for living-donor kidney and 2-4 weeks for living-donor liver transplants, with 1-year survival rates of >95% for kidney and 85-92% for liver (exceeding Score 5 benchmarks)
    • Transplant costs 60-80% below US comparators ($13,000-24,000 for kidney vs ~$442,500 in US)
    • Documented organ trafficking networks with recent arrests and investigations (July 2024 arrest of surgeon, 2023 Jaipur investigation, 2025 Al Jazeera investigation) raising ethical concerns about ecosystem integrity
    • Deceased-donor organs essentially inaccessible to foreigners (only 9 of 1,851 foreign transplants in 2023), with India's 0.81 pmp donation rate among the lowest globally and legal rules placing foreigners last in allocation

    Read the full India report →

  3. 3 Thailand TH 4.5/5 Good Thailand demonstrates excellent transplant infrastructure with 26 centers, multiple JCI accreditation, 4+ organ types, and outcomes exceeding Score 5 thresholds (97-99% kidney survival, 93.6% liver, 85-90% heart at 1 ... Full report
    The evidence behind this score 6 cited points
    • 26 transplant centers nationwide with 62 JCI-accredited organizations; major centers (Bumrungrad, Bangkok Hospital, BNH, Samitivej, Vejthani) serve international patients
    • Wait times 2-3 months for living donor transplants, well under 6-month threshold
    • Kidney survival rates 97.2% (deceased) and 99.4% (living) at 1 year; liver 93.6%; heart 85-90%—all exceeding Score 5 thresholds
    • Kidney transplant costs $28,000-40,000 representing 50-70% savings vs. Western countries
    • International patients cannot access deceased donor organs; must bring blood-related or spouse donors as per Medical Council regulations
    • Strong post-transplant care with surgeon/nephrologist collaboration and defined immunosuppression protocols

    Read the full Thailand report →

  4. 4 United Arab Emirates AE 4.0/5 Good The UAE has multiple internationally accredited transplant centers (CCAD, SKMC, King's College Hospital Dubai, Burjeel) with five organ types and excellent survival rates (95%+ kidney/liver at 1 year, comparable to to... Full report
    The evidence behind this score 5 cited points
    • Five organ types available at CCAD (kidney, liver, heart, lung, pancreas) with 95% overall success rate; SKMC reports 99% one-year and 98% five-year kidney survival
    • Deceased-donor wait times: 3 months (blood type AB) to 3-5 years (blood type O); living-donor programs offer faster access and are the primary medical tourism pathway
    • Federal Decree Law No. 25 of 2023 prohibits organ commercialization and provides nationality-neutral legal framework; deceased-donor list requires UAE residency
    • Kidney transplant costs ~USD 30,000 (93% savings vs US); liver ~USD 200,000 (30-60% savings vs US/UK)
    • Comprehensive international patient services across major centers including visa facilitation, accommodation, multilingual support, and long-term follow-up coordination

    Read the full United Arab Emirates report →

  5. 5 Turkey TR 4.0/5 Good Turkey demonstrates excellent transplant infrastructure with 46-50 JCI-accredited hospitals, multiple organ types available (kidney, liver, heart, lung, pancreas), and exceptional clinical outcomes (94-96% kidney graf... Full report
    The evidence behind this score 5 cited points
    • 46-50 JCI-accredited hospitals with transplant programs available, far exceeding 2-3 centers required for Score 4
    • Kidney transplant 1-year graft survival of 94% overall and 96% for living donors; liver transplant 1-year survival exceeds 90% (exceeds Score 4/5 thresholds of 85%+ kidney/liver)
    • Wait times of 3-4 weeks for international patients with living donors (far better than 6-12 month Score 4 window)
    • Cost savings of 50-70% compared to US/UK/Canada, meeting Score 5 criteria
    • International patients restricted to living donor transplants only; must bring their own donors; no access to deceased donor organs due to Turkish law

    Read the full Turkey report →

  6. 6 Jordan JO 3.5/5 Moderate Jordan operates 4 internationally accredited transplant centers with competitive kidney outcomes (91-97% one-year survival) and exceptional cost savings (85-90% below US pricing), supported by well-developed internati... Full report
    The evidence behind this score 5 cited points
    • 4 JCI-accredited transplant centers in Amman (Jordan Hospital, Specialty Hospital, PHCUOT, Arab Medical Center)
    • Kidney transplant success rates of 91-97% at 1 year, exceeding international benchmarks
    • Only 2 organ types available to international patients (kidney and liver); heart program suspended since 2020; lung and pancreas not offered
    • Living-donor-only legal requirement (relatives up to fifth degree or spouses); deceased-donor program non-functional with 0.3 per million population donation rate
    • Cost savings of 85-90% vs US pricing (USD $15,000-$25,000 for kidney transplant vs USD $150,000-$450,000+ in US)

    Read the full Jordan report →

  7. 7 Germany DE 3.5/5 Moderate Germany operates world-class transplant infrastructure with exceptional survival rates (96% kidney, 91-92% lung at 1 year) and sophisticated ethical oversight, but presents structural constraints for international med... Full report
    The evidence behind this score 5 cited points
    • Heidelberg University Hospital operates dedicated international patient division with 240+ annual transplants (140 kidney, 100 liver) offering visa support, interpreters, and comprehensive treatment services
    • Transplant outcomes exceed international benchmarks: kidney 96% one-year graft survival, lung 91-92%, heart 86-88% per DSO and IQTIG data
    • Deceased-donor kidney wait times: 5.8-7 years for Eurotransplant-eligible patients; non-EU nationals effectively excluded from deceased-donor waiting lists
    • Living-donor pathway shows 2-6 month wait once donor approved, but restricted by Transplantationsgesetz to close relatives or documented personal relationships, limiting international access
    • Cost structure: kidney $17,000-$105,000 (vs US $200,000-$250,000) represents 30-50% savings, comparable to Western European destinations but not competitive with lower-income countries

    Read the full Germany report →

  8. 8 Spain ES 3.5/5 Moderate Spain operates world-class transplant infrastructure with exceptional outcomes (97-99% kidney/liver 1-year survival, 85% heart) and significant cost savings (60-75% below US pricing). It has 3-4 JCI-accredited centers... Full report
    The evidence behind this score 7 cited points
    • 3-4 JCI-accredited transplant centers (Clínica Universidad de Navarra, Hospital Clínic Barcelona/barnaclínic+, Fundació Puigvert, Hospital Ruber Internacional) actively accepting international patients
    • Categorical exclusion of non-residents from deceased-donor waiting list per two-year residency requirement since 2018; non-residents limited exclusively to living-donor programs
    • Outcomes substantially exceed international benchmarks: kidney 97-99% at 1 year, liver 90-99% at 1 year, heart 85.2% at 1 year
    • Kidney transplant costs €70,000-€100,000 providing 60-75% savings versus US pricing of $250,000-$400,000
    • Comprehensive post-transplant care coordination at leading centers; Clínica Universidad de Navarra maintains dedicated international patient team for 110+ countries
    • Only 2-3 organ types accessible to international patients (living-donor kidney, living-donor liver partial, limited heart valve); full heart and lung transplants inaccessible
    • No explicit documentation of annual international transplant volume; Barnaclínic+ performs ~50 living-donor kidney transplants annually but international proportion unclear

    Read the full Spain report →

  9. 9 Singapore SG 3.5/5 Moderate Singapore offers world-class transplant outcomes and infrastructure (5 JCI-accredited centers, 90% 10-year kidney graft survival exceeding US benchmarks, exceptional cost savings of 50-85%) with a clear ethical legal ... Full report
    The evidence behind this score 6 cited points
    • 5 JCI-accredited transplant centers (NUH/NUCOT, SGH, NHCS, Mount Elizabeth, Gleneagles) with global recognition
    • Living-donor kidney: 90% 10-year graft survival (exceeds US 82.7%) and SGH achieved 100% 1-year patient/graft survival (2022-2023)
    • Living-donor liver: SGH reported 100% 1-year patient and graft survival since 2015 with zero living-donor mortality
    • Kidney transplant costs USD 50,999-85,999 vs USD 300,000-400,000 in US; liver USD 148,000-275,000 vs USD 500,000+ in US
    • Clear ethical legal framework: HOTA/MTERA with mandatory Transplant Ethics Committee approval, 7-day mandatory cooling-off period, WHO compliance, absolute prohibition on organ trading
    • Only 2 organ types realistically available to foreigners (living-donor kidney/liver); deceased-donor organs and hearts/lungs essentially inaccessible due to 9-year kidney wait, only 1 heart and 0 lungs performed nationally in 2024

    Read the full Singapore report →

  10. 10 Israel IL 3.0/5 Moderate Israel operates multiple JCI-accredited transplant centers with world-class outcomes (95%+ survival for living-donor kidney, 85-90% for liver/heart) and cost savings of 50-70% below US prices. However, the 2008 Organ ... Full report
    The evidence behind this score 5 cited points
    • Rabin Medical Center performs all five solid organ types (kidney, liver, heart, lung, pancreas) with cumulative experience of 2,500+ kidney, 500+ liver, 400+ lung, 100+ heart, and 50+ pancreas transplants, but deceased-donor organs are legally prohibited to non-residents
    • Multiple JCI-accredited centers (Sheba since 2013, Rabin, Sourasky, Hadassah) available for living-donor cases, exceeding the '1-2 centers' threshold of Score 3 on infrastructure alone
    • Kidney living-donor survival rates of 95% at 1 year and liver survival of 85-90% substantially exceed international benchmarks and Score 3 expectations
    • Cost savings of 50-70% for kidney transplants ($80,000-142,000 vs. US ~$442,500) exceed all score levels except 5, but limited to living-donor cases for foreigners
    • Non-residents legally barred from deceased-donor organs per 2008 Organ Transplant Law; foreign nationals eligible only for living-donor transplants from first-degree relatives with Ministry of Health Special Committee approval, fundamentally restricting organ types available to international patients

    Read the full Israel report →

  11. 11 United Kingdom GB 2.5/5 Moderate The UK operates world-class transplant centres with survival rates exceeding international benchmarks (99% for living-donor kidney, 88.5% for liver, >95% for heart), but access for international patients is severely r... Full report
    The evidence behind this score 5 cited points
    • Only 3-4 private transplant centers accept international patients, limited to living-donor kidney and liver pathways
    • Deceased-donor organs explicitly restricted to NHS-eligible (UK-resident) patients by law and policy; no access for foreigners to most organ types
    • Survival rates are world-class where accessible: 99% one-year patient survival for living-donor kidney, 88.5% for liver, >95% for heart
    • No cost savings: kidney transplant costs £40,000-55,000, comparable to Germany/France and 2-4x higher than India/Turkey
    • Report concludes: 'The United Kingdom is not a primary organ transplant destination for medical tourists'

    Read the full United Kingdom report →

  12. 12 Poland PL 2.5/5 Moderate Poland operates multiple well-equipped transplant centers with outcomes broadly aligned with international benchmarks (kidney 1-year survival 95%, liver 84%), but the system is fundamentally oriented toward domestic p... Full report
    The evidence behind this score 8 cited points
    • Only ~30 foreign nationals on waiting list in 2022, overwhelmingly Ukrainian residents, not elective medical tourists
    • Average kidney transplant wait time 430 days (up to 12 years for longest-waiting), far exceeding medical tourism feasibility
    • No JCI or international accreditation for transplant programs; no fast-track or premium programs for foreign patients
    • Living-donor kidney transplants at only 0.8 per million population—among Europe's lowest; paired-kidney exchange program nascent
    • Poland not a member of Eurotransplant and organ transplants explicitly excluded from EU cross-border healthcare reimbursement
    • Multiple high-volume centers (Warsaw UCC MUW, Silesian Centre) with good transplant outcomes (kidney 95% 1-year, liver 84%, heart ~75%) and institutional experience
    • Clear ethical framework and no documented organ trafficking; cost savings 40–70% below Western Europe; 22% annual growth in transplant volumes
    • No published pricing, all-inclusive packages, or dedicated international patient coordinators; country ranked 29th of 46 in Medical Tourism Index and not listed among transplant tourism destinations

    Read the full Poland report →

  13. 13 Malaysia MY 2.5/5 Moderate Malaysia has JCI-accredited transplant centers with international patient infrastructure, but faces critical constraints that severely limit transplant tourism viability. The deceased donor shortage (1.33 pmp, one of ... Full report
    The evidence behind this score 5 cited points
    • Deceased donor kidney wait time: 13-15 years with only 82 cadaveric donations utilized in all of 2024; deceased donor organs allocated to domestic patients only
    • Liver transplant one-year survival: 73.9% (below international benchmark of 85-90%)
    • Very limited surgical capacity: only 2 transplant surgeons in public system; no formal transplant surgery training program
    • Malaysia explicitly not a primary transplant tourism destination; no evidence of serving 100+ international patients annually
    • JCI-accredited centers (IJN since 2009, Gleneagles KL, SJMC) with international patient services and cost savings of 65-93% versus US

    Read the full Malaysia report →

  14. 14 Japan JP 2.0/5 Poor Japan has world-class transplant infrastructure and excellent outcomes (heart 10-year survival 93.5%, kidney living-donor 5-year >96%, liver 5-year 85–95%), but is practically inaccessible for international medical to... Full report
    The evidence behind this score 5 cited points
    • Only 1 JCI-accredited transplant center (Fujita) with explicit international patient program; Fujita performs 500+ total transplants but publishes no international volumes
    • Deceased-donor kidney wait times 13–18.7 years (versus Score 2 threshold of 24+ months); living-donor kidney transplants constitute 85% of volume but are restricted to blood relatives, eliminating primary access pathway for medical tourists
    • Excellent transplant outcomes across all organs (heart 10-year 93.5%, kidney living-donor 5-year >96%, liver 5-year 85–95%, pancreas 1-year 95.8%) but world-class quality is irrelevant if inaccessible
    • Active Declaration of Istanbul commitment and institutional anti-transplant-tourism stance create de facto barriers despite no formal legal prohibition on foreign patients
    • Estimated uninsured kidney transplant cost ~USD 100,000–167,000 year-one (comparable to Western prices), with no published international pricing structure or cost advantage

    Read the full Japan report →

  15. 15 Hungary HU 2.0/5 Poor Hungary operates world-class transplant infrastructure with elite rankings at Semmelweis University (1st among 77 Eurotransplant centers for kidney, 2nd in Europe for heart), covering five organ types across seven cen... Full report
    The evidence behind this score 6 cited points
    • Non-resident foreign patients explicitly excluded from transplant waiting list by Act CLIV of 1997
    • EU Cross-Border Healthcare Directive (2011/24/EU) explicitly excludes organ transplants from coverage
    • Zero documented international transplant patients; 411 total transplants in 2025 all domestic/Eurotransplant exchange
    • No published pricing for foreign patients; system is public university hospital-based with no commercial infrastructure
    • Semmelweis University ranked 1st among 77 Eurotransplant centers for kidney transplants and 2nd in Europe for heart, indicating elite technical quality incompatible with accessibility restrictions
    • Living-donor transplant theoretical pathway exists but no documented protocol for foreign patients; would require case-by-case institutional approval

    Read the full Hungary report →

  16. 16 United States US 2.0/5 Poor Despite world-class transplant infrastructure and exceptional outcomes, the United States is poorly suited for medical tourism due to prohibitive costs (kidney ~$447K, heart ~$1.9M—7-30× more expensive than alternativ... Full report
    The evidence behind this score 5 cited points
    • Only ~0.4% of US transplants (~40 annually) go to foreign nationals traveling specifically for transplantation, with 1.4% overall to non-US residents
    • Deceased donor wait times average 3-5 years for kidneys, 1-5 years for livers—far exceeding the 24-month threshold and making deceased donor access impractical for medical tourists
    • Kidney transplant costs average $446,800 billed charges; heart transplants ~$1.9M—the highest in the world and 7-30× more expensive than leading medical tourism competitors
    • January 2026 House Ways and Means Committee investigation into University of Chicago Medical Center and Montefiore Medical Center for allegedly providing disproportionately fast organ access to wealthy foreign nationals raises concerns about ethical practices
    • While 1-year kidney survival (97.4%), liver survival (85-90%), and heart survival (~95%) are world-class, these exceptional outcomes do not overcome fundamental unsuitability for medical tourism due to cost, wait time, and access barriers

    Read the full United States report →

  17. 17 Colombia CO 2.0/5 Poor While Colombia possesses world-class transplant infrastructure with multiple JCI-accredited centers and excellent outcomes for kidney and liver transplants (97.2% and 82-90% 1-year survival respectively), prohibitive ... Full report
    The evidence behind this score 5 cited points
    • Law 1805 of 2016 and Constitutional Court ruling C-372-19 explicitly prohibit organ transplantation for non-resident foreigners except through living-related donor cases with dual-country government authorization
    • Only 5-10 foreign patients transplanted annually (vs 100+ for score 4, 200+ for score 5)
    • Non-resident foreigners legally barred from national organ waiting list; no access to deceased-donor organs
    • Multiple JCI-accredited transplant centers (Valle de Lili, HIC, Fundación Santa Fe, Hospital Pablo Tobón Uribe) spanning 6 organ types
    • Exceptional kidney transplant outcomes of 97.2% at 1 year and liver transplants of 82-90%, with cost savings of 50-70% below US/European levels

    Read the full Colombia report →

  18. 18 Brazil BR 2.0/5 Poor Brazil operates world-class transplant infrastructure with multiple JCI-accredited centers and excellent kidney transplant outcomes (94% 1-year living donor survival), but Federal Law 9,434/1997 effectively prohibits ... Full report
    The evidence behind this score 7 cited points
    • Federal Law 9,434/1997 prohibits organ allocation to non-resident aliens, barring access to deceased donor organs
    • Living donor transplants restricted to biological relatives up to 4th degree or spouses; unrelated donors require judicial authorization
    • 127 kidney, 59 heart, and 14 lung transplant centers exist but functionally closed to most international patients
    • Living donor kidney survival rates excellent at 94% (1-year), 86% (5-year); heart transplant outcomes below international benchmarks at 68.1% (1-year)
    • Altruistic donor chains and paired kidney exchanges explicitly forbidden
    • No clear evidence of 100+ annual international transplant patients
    • Multiple JCI-accredited private hospitals (Hospital Israelita Albert Einstein, Hospital Sírio-Libanês) maintain international patient divisions but capacity remains severely restricted by law

    Read the full Brazil report →

  19. 19 Mexico MX 2.0/5 Poor Mexico has capable transplant infrastructure with multiple JCI-accredited centers and excellent survival rates (94-97% at 1 year for top centers), offering 50-70% cost savings compared to the US. However, the mandator... Full report
    The evidence behind this score 5 cited points
    • Mandatory 6-month residency requirement for foreign patients prior to transplant eligibility
    • 8 JCI-accredited hospitals with transplant programs serving Mexico City, Cancun, Tijuana and other major cities
    • Excellent survival rates: 94% at 1 year for liver transplants at leading center, 97.2% patient survival and 95.5% graft survival for kidney transplants
    • Significant cost savings: kidney transplants $22-35K vs US prices, liver transplants $70-150K vs $575-875K in US
    • Report concludes residency requirement 'effectively eliminates Mexico as a viable option for most international patients seeking immediate transplantation'

    Read the full Mexico report →

Reading the field

What separates a good programme from a dangerous one

Every country above is graded against this published scale — the same 1–5 rubric for transplant capabilities, top to bottom. How we score →

  1. 5/5 Excellent

    Multiple internationally accredited transplant centers serving foreign patients across 4+ organ types. Wait times under 6 months for most organs, with robust living donor programs. Transplant survival rates at 1 year exceed 90% for kidney/liver, 85% for heart. Clear legal framework supporting ethical transplant tourism. Comprehensive post-transplant care coordination. Costs 50-70% below US/European levels. Evidence of 200+ annual transplants for international patients.

  2. 4/5 Good

    2-3 accredited transplant centers with 3+ organ types available to foreigners. Wait times 6-12 months for most organs. Survival rates meet international standards (85%+ kidney/liver, 80%+ heart at 1 year). Established legal framework with some restrictions. Good post-transplant support systems. Moderate cost savings of 30-50%. Evidence of 100+ annual international transplant patients.

  3. 3/5 Moderate

    1-2 transplant centers accepting international patients, primarily kidney and liver programs. Wait times 12-24 months. Survival rates slightly below international averages but acceptable (80%+ kidney/liver). Basic legal framework with unclear regulations for foreigners. Limited post-transplant coordination. Cost savings of 20-40%. Some evidence of international transplant activity.

  4. 2/5 Poor

    Single transplant center or very limited international access. Long wait times over 24 months. Below-average survival rates or limited outcome reporting. Unclear or restrictive legal environment. Poor post-transplant support. Minimal cost advantages. Little evidence of serving international patients regularly.

  5. 1/5 Very Poor / Unavailable

    No established transplant programs accepting international patients, or programs with concerning ethical issues. Extremely long waits or no access for foreigners. Poor outcomes or no outcome reporting. Prohibitive legal environment or evidence of organ trafficking concerns. No coordinated international patient services.

The reports

The full country reports under this lens

Each destination we have assessed has a full, cited report — the detailed analysis behind its score. The verdict is free; the report is the depth.

Clinics & providers

The clinics our research names

Named hospitals, clinics and centres cited across these findings — each carrying the specialties our reports record. Follow one to the reports behind it.

References

The sources behind these assessments

The distinct sources cited across these published reports — every finding carries its own citations; this is the union, each linking back to the reports that lean on it.

  1. Untitled source www.lawsturkey.com/law/2238-organ-transplantation-law Cited in Transplant Capabilities in Turkey
  2. Untitled source agenciabrasil.ebc.com.br/en/saude/noticia/2019-09/brazil-has-worlds-largest-public-organ-transplant-system Cited in Transplant Capabilities in Brazil
  3. Untitled source assets.publishing.service.gov.uk/media/57a08c11ed915d622c0010df/WP04_03.pdf Cited in Transplant Capabilities in Thailand
  4. Untitled source avrupahairtransplant.com/turkiye/success-rate Cited in Transplant Capabilities in Turkey
  5. Untitled source bangkokhealthservice.com/bangkok-a-beacon-of-hope-for-heart-transplant-patients Cited in Transplant Capabilities in Thailand
  6. Untitled source bi-maristan.com/en/articles/organ-transplant-cost-turkey Cited in Transplant Capabilities in Turkey
  7. Untitled source bi-maristan.com/en/general-surgery/organ-transplant/kidney-transplant Cited in Transplant Capabilities in Turkey
  8. Untitled source centromedicoabc.com/en/transplant-center Cited in Transplant Capabilities in Mexico
  9. Untitled source centromedicoabc.com/en/transplant-center/organ-donation Cited in Transplant Capabilities in Mexico
  10. Untitled source clinicsoncall.com/en/clinics/country-mexico/surgery/procedure-transplantology Cited in Transplant Capabilities in Mexico
  11. Untitled source curemeabroad.com/treatments/organ-transplant/kidney-transplant/israel Cited in Transplant Capabilities in Israel
  12. Untitled source declarationofistanbul.org Cited in Transplant Capabilities in Turkey
  13. Untitled source discoverinternationalmedicalservice.com Cited in Transplant Capabilities in Thailand
  14. Untitled source dmcquote.com/guides/medical-tourism-thailand Cited in Transplant Capabilities in Thailand
  15. Untitled source documentation.lastradainternational.org/doc-center/1724/declaration-of-istanbul-on-organ-trafficking-and-transplant-tourism-call-for-organ-trafficking-ban Cited in Transplant Capabilities in Turkey
  16. Untitled source donatelifecalifornia.org/education/how-donation-works/the-organ-transplant-waiting-list Cited in Transplant Capabilities in Turkey
  17. Untitled source en.uniclinics.com/medical-tourism/turkey/treatment-in-turkey Cited in Transplant Capabilities in Turkey
  18. Untitled source en.wikipedia.org/wiki/Declaration_of_Istanbul Cited in Transplant Capabilities in Turkey, Transplant Capabilities in Mexico
  19. Untitled source en.wikipedia.org/wiki/Medical_tourism_in_South_Korea Cited in Transplant Capabilities in South Korea
  20. Untitled source en.wikipedia.org/wiki/Thai_Red_Cross_Society Cited in Transplant Capabilities in Thailand
  21. Untitled source english.redcross.or.th/aboutus/department/organdonate Cited in Transplant Capabilities in Thailand
  22. Untitled source esot.org/team/turkish-transplant-foundation Cited in Transplant Capabilities in Turkey
  23. Untitled source fibohealth.com/organ-transplantation Cited in Transplant Capabilities in Turkey
  24. Untitled source gracetouchclinic.com/what-is-the-success-rate-of-hair-transplant Cited in Transplant Capabilities in Turkey

Explore the source archive →

In plain language

Start exploring the knowledge base

The field's shorthand our reports use, sized by how often it comes up. Follow any term to its full entry and the reports that use it.

For readers weighing this decision

Ways to read the evidence

The verdict is always free. A membership opens the full analysis and every cited source — this specialty, the whole library, or everything for good.

  • One specialty · annual

    Therapeutic Interventions

    $49.00 / year

    $49.00/year

    Every report in this specialty — full analysis and every cited source — as each is published.

    Take this specialty

  • Full library · annual

    The whole library

    $199.00 / year

    $199.00/year

    The complete evidence behind every finding in every specialty, while your decision is live.

    Take the full library
  • Most readers

    Lifetime · one payment

    Everything, for good

    $499.00 once

    $499.00 (one-time)

    Every finding we publish today and hereafter — no renewal, no expiry. The tier we point most readers to.

    Take lifetime access

Prefer to pay per report? A single report is $29.00, yours to keep — browse the reports. The verdict is always free.

Where to go from here · Transplant Capabilities

no scope is a dead end — step up to the specialty, drill into a factor, or pivot across to a country or a comparison